DOUBLE-EXPRESSOR LYMPHOMA
Clinical trials for DOUBLE-EXPRESSOR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new DOUBLE-EXPRESSOR LYMPHOMA trials appear
Sign up with your email to follow new studies for DOUBLE-EXPRESSOR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets aggressive lymphomas in early trial
Disease control Recruiting nowThis study tests a new drug called pidnarulex (CX-5461) in people with certain fast-growing lymphomas linked to the MYC gene. The goal is to find a safe dose and see if it can shrink tumors. About 50 adults who have already tried other treatments will take part.
Matched conditions: DOUBLE-EXPRESSOR LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:57 UTC
-
New hope for hard-to-treat lymphoma: targeted therapy plus chemo shows promise
Disease control Recruiting nowThis study tests a two-step treatment for people with a fast-growing type of lymphoma that hasn't been treated yet. First, a targeted drug (loncastuximab tesirine) plus rituximab is given, followed by a standard chemotherapy cocktail (DA-EPOCH-R). The goal is to see if this appro…
Matched conditions: DOUBLE-EXPRESSOR LYMPHOMA
Phase: PHASE2 • Sponsor: Joseph Tuscano • Aim: Disease control
Last updated May 26, 2026 09:54 UTC